跳至主要内容
临床试验/ACTRN12613000765729
ACTRN12613000765729招募中未知

A Single-blind, randomised non inferiority study of the effectiveness and tolerability of picosalax and low residue diet compared to standard bowel preparation prior to morning colonoscopy

Alfred Hospital0 个研究点目标入组 250 人开始时间: 2013年7月9日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Diagnosis
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • Consenting adult patients (aged 18 years and greater) undergoing outpatient colonoscopy for clinically accepted indications.
  • Clinically accepted indications generally include but are not restricted to iron deficiency anaemia, surveillance of bowel polyps, colorectal cancer screening, assessment of symptoms such as abdominal pain, diarrhoea and constipation, assessment or investigation of inflammatory bowel disease.

排除标准

  • Exclusion criteria are conditions generally considered as exclusions to colonoscopy in normal clinical practice.
  • They are suspected bowel perforation, gastric outlet obstruction, toxic megacolon, severe colitis, and pregnancy or lactation.
  • For additional safety, will also exclude patients with the relative contraindications of significant renal failure (eGFR<30) significant heart failure (New York Heart Association Class III or IV).
  • Prep-Kit C is contraindicated in individuals with phenylketonuria, due to the presence of aspartame and patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency given it contains ascorbic acid (vitamin C) which is an oxidant. Any person with a known hypersensitivity to a constituent of Picoprep, Glycoprep or Picosalax will also be excluded.

研究者

发起方
Alfred Hospital

相似试验